Skip to main content
H

Henan Lingrui Pharmaceutical Co., Ltd — Investor Relations & Filings

Ticker · 600285 LEI · 300300NNZECAUBZEA076 Shanghai Stock Exchange Manufacturing
Filings indexed 1,557 across all filing types
Latest filing 2026-04-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600285

About Henan Lingrui Pharmaceutical Co., Ltd

Henan Lingrui Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of pharmaceutical products, with a primary focus on transdermal drug delivery systems. The company is a prominent producer of rubber plasters and external application medicines, notably its range of pain relief patches used for musculoskeletal and joint conditions. Its product portfolio extends to oral formulations, including capsules and tablets targeting cardiovascular health and inflammatory ailments. By integrating traditional medicinal principles with modern delivery technologies, the company provides a diverse array of therapeutic solutions. Its operations encompass the entire value chain from raw material processing to large-scale production and distribution, maintaining a significant presence in clinical and consumer healthcare markets through its specialized focus on external analgesic treatments.

Recent filings

Filing Released Lang Actions
羚锐制药关于会计师事务所2025年度履职情况评估报告
Regulatory Filings
2026-04-27 Chinese
董事会审计委员会2025年度履职情况报告
Regulatory Filings
2026-04-27 Chinese
羚锐制药审计报告
Regulatory Filings
2026-04-27 Chinese
独立董事候选人声明与承诺(王钊)
Regulatory Filings
2026-04-27 Chinese
羚锐制药2025年度利润分配方案公告
Regulatory Filings
2026-04-27 Chinese
羚锐制药关于大股东部分股份质押的公告
Regulatory Filings
2026-03-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.